Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur–0.4 M gimestat–1 M otastat potassium) in advanced gastric cancer patients von Sakata, Y, Ohtsu, A, Horikoshi, N, Sugimachi, K, Mitachi, Y, Taguchi, T

Volltext

Phase II study of S-1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinoma von Ohtsu, A, Baba, H, Sakata, Y, Mitachi, Y, Horikoshi, N, Sugimachi, K, Taguchi, T

Volltext

Possible Relationship Between the Risk of Japanese Bladder Cancer Cases and the CYP4B1 Genotype von Sasaki, Takamitsu, Horikawa, Miho, Orikasa, Kazuhiko, Sato, Makoto, Arai, Yoichi, Mitachi, Yoshitaka, Mizugaki, Michinao, Ishikawa, Masaaki, Hiratsuka, Masahiro

Volltext

Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis von Ohkusa, T., Maekawa, T., Arakawa, T., Nakajima, M., Fujimoto, K., Hoshino, E., Mitachi, Y., Hamada, S., Mine, T., Kawahara, Y., Nagai, T., Aoyama, N., Yoshida, N., Tadokoro, K., Chida, N., Konda, Y., Seno, H., Shimatani, T., Inoue, M., Sato, N.

Volltext

Moderate Neutropenia with S-1 Plus Low-dose Cisplatin May Predict a More Favourable Prognosis in Advanced Gastric Cancer von Nakata, B., Tsuji, A., Mitachi, Y., Yamamitsu, S., Hirata, K., Takeuchi, T., Shirasaka, T., Hirakawa, K.

Volltext

Phase II study of oral S‐1 for treatment of metastatic colorectal carcinoma von Shirao, Kuniaki, Ohtsu, Atsushi, Takada, Hideho, Mitachi, Yasushi, Hirakawa, Kosei, Horikoshi, Noboru, Okamura, Takeshi, Hirata, Koichi, Saitoh, Soh, Isomoto, Hiroharu, Satoh, Atsushi

Volltext

An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal Cancers von Sugimachi, Keizo, Maehara, Yoshihiko, Horikoshi, Noboru, Shimada, Yosuhiro, Sakata, Yuh, Mitachi, Yasushi, Taguchi, Tetsuo

Volltext

Combination Phase I Trial of a Novel Oral Fluorouracil Derivative S-1 with Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27–9902) von NAKATA, Bunzo, MITACHI, Yasushi, TSUJI, Akihito, YAMAMITSU, Susumu, HIRATA, Koichi, SHIRASAKA, Tetsuhiko, HIRAKAWA, Kosei

Volltext

A Phase I Study of Combination Therapy of the Oral Fluorinated Pyrimidine Compound S-1 with Low-dose Cisplatin Twice-a-week Administration (JFMC27-9902 Step2) in Patients with Adva... von Morita, Satoshi, Nakata, Bunzo, Tsuji, Akihito, Mitachi, Yasushi, Shirasaka, Tetsuhiko, Saji, Shigetoyo, Ohashi, Yasuo, Sakamoto, Junichi, Hirakawa, Kosei

Volltext

Combination therapy of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer: JFMC27–9902 phase I trial von Nakata, B., Tsuji, A., Mitachi, Y., Yamamitsu, S., Hirata, K., Shirasaka, T., Saji, S., Inokuchi, K., Hirakawa, K.

Volltext

Combination therapy of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer: JFMC27–9902 phase I trial von Nakata, B., Tsuji, A., Mitachi, Y., Yamamitsu, S., Hirata, K., Shirasaka, T., Saji, S., Inokuchi, K., Hirakawa, K.

Volltext

Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group von Ohtsu, A, Baba, H, Sakata, Y, Mitachi, Y, Horikoshi, N, Sugimachi, K, Taguchi, T

Volltext

An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. The S-1 Gastrointestinal Cancer Study Group von Sugimachi, K, Maehara, Y, Horikoshi, N, Shimada, Y, Sakata, Y, Mitachi, Y, Taguchi, T

Volltext

Phase II study of raltitrexed (Tomudex®) in chemotherapy-pretreated patients with advanced colorectal cancer von Sato, Atsushi, Kurihara, Minoru, Horikoshi, Noboru, Aiba, Keisuke, Kikkawa, Nobuteru, Shirouzu, Kazuo, Mitachi, Yasushi, Sakata, Yuh, Wakui, Akira

Volltext

Detection of APC mutations by a yeast-based protein truncation test (YPTT) von Suzuki, Takao, Ishioka, Chikashi, Kato, Satoshi, Mitachi, Yasushi, Shimodaira, Hideki, Sakayori, Masato, Shimada, Akira, Asamura, Mitsuo, Kanamaru, Ryunosuke

Volltext

Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study Group von Sato, A, Kurihara, M, Horikoshi, N, Aiba, K, Kikkawa, N, Shirouzu, K, Mitachi, Y, Sakata, Y, Wakui, A

Volltext

Induction of natural killer (NK) activity in mice by injection of chromomycin A sub(3) von Kambe, M, Kanamaru, R, Mitachi, Y, Wakui, A

Volltext

Induction of Natural Killer (NK) Activity in Mice by Injection of Chromomycin A3 von KAMBE, MARIKO, KANAMARU, RYUNOSUKE, MITACHI, YASUSHI, WAKUI, AKIRA

Volltext

Responsiveness of Peripheral Blood Lymphocytes from Cancer Patients and Healthy Donors to Interleukin-2 (IL-2) von KAMBE, MARIKO, MITACHI, YASUSHI, KANAMARU, RYUNOSUKE, WAKUI, AKIRA

Volltext

Imbalance of T Cell Subsets in Cancer Patients and Its Modification with Bestatin, a Small Molecular Immunomodifier von KUMANO, NOBUKO, SUZUKI, SHUJI, OIZUMI, KOTARO, KONNO, KIYOSHI, HIMORI, TATSUMI, MITACHI, YASUSHI, WAKUI, AKIRA

Volltext